Your browser doesn't support javascript.
loading
Sustained response to lenalidomide for early relapsed marginal zone lymphoma.
Ibrahimi, Sami; Vidal, Gabriel; Mukherjee, Sarbajit; Alhyari, Laith; Scordino, Teresa; Cherry, Mohamad.
Afiliação
  • Ibrahimi S; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: Sami-ibrahimi@ouhsc.edu.
  • Vidal G; University of Oklahoam Health Sciences Center, Dept. of Internal Medicine, Oklahoma City, OK, United States.
  • Mukherjee S; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Alhyari L; University of Oklahoma Health Sciences Center, Dept. of Radiology, Oklahoma City, OK, United States.
  • Scordino T; University of Oklahoma Health Sciences Center, Dept. of Pathology, Oklahoma City, OK, United States.
  • Cherry M; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Blood Cells Mol Dis ; 71: 53-54, 2018 07.
Article em En | MEDLINE | ID: mdl-29496374
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Inibidores da Angiogênese / Lenalidomida Limite: Female / Humans / Middle aged Idioma: En Revista: Blood Cells Mol Dis Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Inibidores da Angiogênese / Lenalidomida Limite: Female / Humans / Middle aged Idioma: En Revista: Blood Cells Mol Dis Ano de publicação: 2018 Tipo de documento: Article